Semaglutide: A Promising Ally Against Alzheimer’s?
In a groundbreaking study, researchers at Case Western Reserve School of Medicine have identified a potential new benefit of semaglutide, a widely used diabetes and weight-loss drug. According to their findings, semaglutide may significantly reduce the risk of Alzheimer’s disease in individuals with type 2 diabetes (T2D), outperforming seven other anti-diabetic medications.
Alzheimer’s disease, a devastating brain disorder that erodes memory and cognitive abilities, affects nearly 7 million Americans aged 65 and older, as reported by the Alzheimer’s Association. Alarmingly, it claims more lives annually than breast and prostate cancer combined.
Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, the study suggests that T2D patients taking semaglutide had a markedly lower risk of developing Alzheimer’s disease. This trend was consistent across various subgroups, regardless of obesity status, gender, or age.
Semaglutide, a glucagon-like peptide receptor (GLP-1R) agonist, is the active ingredient in popular medications like Wegovy and Ozempic. It works by reducing hunger and regulating blood sugar levels in T2D patients.
Under the leadership of Rong Xu, a professor of biomedical informatics, the research team analyzed three years of electronic health records from nearly one million U.S. patients with T2D. Their statistical approach, which mimicked a randomized clinical trial, revealed that patients prescribed semaglutide had a significantly lower risk of Alzheimer’s compared to those on other anti-diabetic medications.
According to the CDC, Alzheimer’s disease results in approximately 120,000 deaths annually, ranking as the seventh-leading cause of death in the United States.
“This new study provides real-world evidence for semaglutide’s potential impact on Alzheimer’s disease,” Xu stated. “While preclinical research has hinted at its protective effects against neurodegeneration and neuroinflammation, our findings suggest the need for further exploration through randomized clinical trials.”
Despite these promising results, the study’s limitations prevent researchers from drawing definitive causal conclusions. Xu emphasized the importance of continued research into semaglutide’s potential as a treatment for this debilitating condition, encouraging further investigation into alternative drugs.
For more information, please contact Patty Zamora at [email protected].
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
The Western U.S. commercial real estate sector is gearing up for a pivotal year in 2026, with new forecasts from Kidder Mathews showing steady economic growth, moderating inflation, and improving fundamentals across office, industrial, retail, and multifamily markets. From slow but stabilizing office recovery to strong retail performance and tightening industrial demand, the region is entering a period of rebalancing that presents fresh opportunities for real estate and related professionals.
A delayed federal jobs report has pushed ADP’s data into the spotlight, revealing that private employers added just 22,000 jobs in January — far below expectations. Revised December numbers and ongoing declines in key sectors like professional services and manufacturing point to a cooling labor market heading into 2025. While wage growth remains steady, uneven job creation across regions and industries is raising new questions about future interest‑rate cuts and what this shifting economy means for professionals in fields like real estate, mortgage, insurance, and finance.
Nashville’s booming tech-driven population is transforming luxury real estate, making smart technology and eco‑friendly design the new standard. From AI‑powered adaptive living and advanced security systems to high‑efficiency construction and green incentives, the city’s top communities—Brentwood, Franklin, and Nolensville—are leading a movement toward intelligent, energy‑saving homes that offer long‑term value and modern comfort.
Florida legislators have confirmed that no new insurance relief is coming in 2026, leaving homeowners to grapple with rising premiums and shrinking options. While Republican leaders argue that past reforms simply need more time to stabilize the market, Democrats are pushing for immediate action as families across the state feel the financial strain. With insurance changes off the table, lawmakers are shifting their focus to property tax relief—creating important ripple effects for real estate, mortgage, and insurance professionals watching the market closely.
A new CBRE survey reveals that 2026 is shaping up to be a bullish year for commercial real estate, with most investors planning to expand their portfolios. Dallas secures the top spot for the fifth year in a row, but Southeast metros like Atlanta, Miami, Tampa, and Charlotte are rapidly gaining ground thanks to population growth, strong job creation, and resilient demand in sectors like tech, logistics, and healthcare.
Washington State University’s Carson College of Business has introduced Carson Pro, a flexible online platform offering non‑credit certificates in finance, management, marketing, accounting, and specialty fields like the business of aging and wine business management. Designed for working professionals seeking practical, career-ready skills or a complete career reset, the program reflects a nationwide shift toward continuous learning as industries—from real estate to finance—evolve at a rapid pace.
